Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J3380 (Entyvio) Fee Schedule
Medicare rates as of October 2026
HCPCS J3380 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
Injection, vedolizumab, intravenous, 1 mg
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11 - Office |
| Complexity Level | Low |
| Medicare Fee Schedule | $20.95 per 1 mg (October 2026 ASP) · View Medicare rates for J3380 |
| Medicaid Fee Schedule | $20.785 median of the 8 states in the free preview · View Medicaid rates for J3380 |
| Medicare Payment Limit | $21.311  |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 64764-0300-20 - ENTYVIO (SDV,PF,LYOPHILIZED) 300 MG |
National average reimbursement for HCPCS J3380 by major payers:
$24.93
BCBS / Anthem
$23.13
UnitedHealthcare
$25.48
Aetna
$23.77
Cigna
Compare published rates across providers.
Choose a payer to see a sample of rates for HCPCS J3380.
HCPCS J3380
5 of 25 sample ratesHigher to lower in this preview
Joseph Frager
Montefiore Medical Center
$60.75Published ratePhilip Adler
Caremount Medical, P.C.
$23.15Published rateRichard Kelly
Crockett Clinic LLP
$22.87Published rateCesar Garcia
El Paso County Hospital District
$22.26Published rateTaralee Adams
Vmd Primary Providers South Hill Country Texas PLLC
$20.40Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J3380 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J3380. Select one to see its fee schedule.
| Code | Complexity | Description |
|---|---|---|
| 64764-0300-20-NDC | Moderate | ENTYVIO (SDV,PF,LYOPHILIZED) 300 MG |
| J3380-HCPCS | Low | Injection, vedolizumab, intravenous, 1 mg |
| J3385-HCPCS | Moderate | Injection, velaglucerase alfa, 100 units |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J3380. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J3380 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like HCPCS J3380) and we'll show you how you compare in 15 minutes or less.